Home Drug Tariff News
Class 1 Drug Alert - Ionsys Iontophoretic Transdermal System
Janssen-Cilag Ltd are recalling all Ionsys transdermal system stock, irrespective of batch number, to patient level. Some units of one batch of the transdermal system have been found to self-activate which has the potential to cause overdose.
Medical advice is that the device should be removed from patients immediately, alternative analgesia provided and patients monitored appropriately. Physicians and nursing staff in wards and ITUs should be informed so symptoms of toxicity may be promptly detected.
Medical information can be obtained from Janssen-Cilag Ltd, Medical Information Department on 0800 0323013.
All unused stock of Ionsys should be quarantined and returned for credit via the original supplier. For returns and credit enquiries, please contact Janssen-Cilag Ltd on 01494 567400.
No other Fentanyl products from Janssen-Cilag are affected and these may continue to be used.
For more information, click here.
Posted 30 September 2008